:::

學術成果

:::
搜尋
年至

月至


  • 關鍵字搜尋
  • 期刊論文
    學年度著作著作人
    1004. Chou, W.C., Chou, S.C., Liu, C.Y., Chen, C.Y., Hou, H.A., Kuo, Y.Y., Lee, M.C., Ko, B.S., Tang, J.L., Yao, M., Tsay, W., Wu, S.J., Huang, S.Y., Hsu, S.C., Chen, Y.C., Chang, Y.C., Kuo, Y.Y., Kuo, K.T., Lee, F.Y., Liu, M.C., Liu, C.W., Tseng, M.H., Huang, C.F., Tien, H.F.,2011,TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.,Blood.,118,pp3803-3810 (SCI)郭遠燁
    100Hou, H.A. #, Kuo, Y.Y. #, Lee, M.C., Tang, J.L., Chen, C.Y., Liu, C.Y., Chou, W.C., Huang, C.F., Lee, F.Y., Liu, M.C.,Yao, M., Tien, H.F. ,2011,Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukemia. ,Br J Cancer. ,105,12,pp1927-1933 (SCI)郭遠燁
    100Fukuoka M, Wu YL, Thongprasert S, Sunpaweravong P, Leong SS, Sriuranpong V, Chao TY, Nakagawa K, Da-Tong Chu, Saijo N, Duffield E, Rukazenkov Y, Speake G, Jiang H, Armour A, To KF, Yang JC, Mok T.,2011,Biomarker Analyses and Final Overall Survival Results from a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients with Advanced Non-Small-Cell Lung Cancer in Asia (IPASS),J Clin Oncol,29,21,pp2866-2874 (SCI)楊志新
    100Salto-Tellez M, Tsao MS, Shih JY, Thongprasert S, Lu S, Chang GC, Au JS, Chou TY, Lee JS, Shi YK, Badruddin RA, Kang JH, Kim SW, Tan SY, Yang JC*,2011,Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations in East Asian Non-Small Cell Lung Cancer (NSCLC) Patients – A Combined Clinical-Molecular Pathological Approach.,J Thorac Oncol.,6,10,pp1663-1669 (SCI)楊志新
    100Girard N, Sima CS, Jackman DM, Sequist LV, Chen HQ, Yang JC, Ji HB, Waltman B, Rosell R, Taron M, Zakowski MF, Ladanyi M, Riely G and Pao W.,2011,Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.(e-publish),European Respiratory J. (SCI)楊志新
    100Chung KP, Huang YT, Chang YL, Yu CJ, Yang CH, Chang YC, Shih JY, Yang PC.,2011,Clinical significance of TTF-1 in advanced lung adenocarcinoma under EGFR tyrosine kinase inhibitor treatment.(e-publish),Chest. (SCI)楊志新
    100Lin CC and Yang CH*.,2011,Optimal management of patients with nonsmall cell lung cancer and EGFR mutation.(review article),Drug,71,1,pp79-81 (SCI)楊志新
    100Chang TH, Tsai MF, Su KY, Wu SG, Huang CP, Yu SL, Yu YL, Lan CC, Yang CH, Lin SB, Wu CP, Shih JY, Yang PC.,2011,Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor,Am J Respir Crit Care Med.,183,8,pp1071-1079 (SCI)楊志新
    100Wu JY, Shih JY, Chen KY, Yang CH, Yu CJ, Yang PC.,2011,Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor mutations.,Medicine.,90,3,pp159-167 (SCI)楊志新
    100Wu JY, Wu SG, Yang CH, Chang YL, Chang YC, Hsu YC, Shih JY, Yang PC.,2011,Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutation.,Lung Cancer ,72,2,pp205-212 (SCI)楊志新